Hep C Genotype Switch

Links shared publicly online about this topic.

  • 0
    total visits

Hep C Genotype Switch

forums.hepmag.com

Hep C Genotype Switch

View full resource at forums.hepmag.com

Tags: Liver Condition, Hepatitis, Hepatitis C, Forum

  • Share

Most Recently Shared on November 16, 2011 at 3:29 pm By:

reganhofmann Regan Hofmann

RT @hepatitismag From Forums : Catching #hepC twice? Member reports have genotype 1a and genotype 4. http://t.co/HEGk3SL6 #Hepatitis #HCV

5 months ago...

Also Shared By:

AIDSmeds AIDSmeds

POZ Magazine POZ Magazine

Vertex Announces 12-Week On-Treatment Data and SVR4 From Phase 2 Study of Interferon-Free (All-Oral) Treatment Regimen of INCIVEK®, VX-222 and Ribavirin in People with Genotype 1 Hepatitis C | EON: Enhanced Online News

eon.businesswire.com — “Vertex Announces 12-Week On-Treatment Data and SVR4 From Phase 2 Study of Interferon-Free (All-Oral) Treatment Regimen of INCIVEK®, VX-222 and RibView full resource at eon.businesswire.com

  • View Related
  • Share

Most Recently Shared on February 23, 2012 at 1:46 pm By:

JohnCFierce John Carroll Health Communicator

Interesting that Vertex is highlighting it can get to an NDA as early as late '14 on its new hep C combo. It's a race. http://t.co/9CF6FtCS

2 months ago...

INCIVO® (Telaprevir) Approved In Europe Offering Higher Cure Rates For Genotype-1 Chronic Hepatitis C Compared To Standard Treatment

jnj.com — “Johnson & Johnson news and information regarding our operations, products, leaders, and our charitable giving.View full resource at jnj.com

  • View Related
  • Share

Most Recently Shared on September 22, 2011 at 1:04 pm By:

eyeonfda eyeonfda Pharma and Health Lawyer

Tibotec gets new #HepC approval in Europe for INCIVO® (telaprevir) - http://ow.ly/6BGuZ

7 months ago...

INCIVO? (Telaprevir) Approved in Europe Offering Higher Cure Rates for Genotype-1 Chronic Hepatitis C Compared to Standard Treatment

prnewswire.co.uk — “INCIVO? (Telaprevir) Approved in Europe Offering Higher Cure Rates for Genotype-1 Chronic Hepatitis C Compared to Standard TreatmentView full resource at prnewswire.co.uk

  • View Related
  • Share

Most Recently Shared on September 20, 2011 at 3:01 pm By:

VertexPharma Vertex Pharma Pharma

Vertex & J&J's new medicine for hep-C approved in Europe: http://t.co/3cXd1K4n

7 months ago...

new hep c treatment - Forum on Hepatitis and HIV Coinfection

thebody.com — “Telaprevir is a new HCV protease inhibitor. It is a very potent drug that is effective against genotype 1 infection. If you are not responding well to pegylated interferon and ribavirin, you may...View full resource at thebody.com

  • View Related
  • Share

Most Recently Shared on September 7, 2011 at 6:01 pm By:

TheBodyDotCom The Body Health Site

Ask the HIV/AIDS Experts: "Did Not Respond Well to Interferon and Ribavirin: Should I Try Telaprevir to Treat My HCV?" http://t.co/dPHQLy4

7 months ago...

HCV New Drug Research: Monday Hepatitis C In The News; HIV Vaccine As Distant Goal,Marijuana,Diabetes,HCV Geno 1 and More

hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: Monday Hepatitis C In The News; HIV Vaccine As Distant Goal,Marijuana,Diabetes,HCV Geno 1 and MoreView full resource at hepatitiscnewdrugs.blogspot.com

  • View Related
  • Share

Most Recently Shared on April 18, 2011 at 5:16 pm By:

HCVNEWDRUGS Tina Banwart - HepatitisCNewDrugs Health Blog

HCV New Drug Research: Monday Just For Fun-What’s in Your Belly Button? http://t.co/bnSMe90

1 year ago...

Vertex Unveils Positive Telaprevir Data | The Haystack

cenblog.org — “Ending months of anticipation, Vertex Pharmaceuticals unveiled the first set of data from a Phase III trial of telaprevir, a protease inhibitor for the treatment of hepatitis C. The company is expected to submit for regulatory approval later this year, and launch the drug in 2011. Vertex said that 75% of genotype-1 patients"viewed as the [...]View full resource at cenblog.org

  • View Related
  • Share

Most Recently Shared on May 25, 2010 at 9:49 pm By:

lisamjarvis Lisa Jarvis Science Enthusiast

Vertex finally unveils PhIII data for telaprevir. Halving treatment time=good, but for how many people?: http://bit.ly/aWLRaO $VRTX

2 years ago...

Advertisement